SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
SCMP
Delisted
SCMP was delisted on the 12th of February, 2018.
81 hedge funds and large institutions have $79.9M invested in Sucampo Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+7
Holders Change %
+9.46%
% of All Funds
2.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
35
Reduced
15
Closed
9
Calls
$1K
Puts
$1.06M
Net Calls
-$1.06M
Net Calls Change
-$973K
Top Buyers
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$3.77M |
| 2 |
Millennium Management
New York
|
+$2.35M |
| 3 |
VAM
Visium Asset Management
New York
|
+$1.87M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.59M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.11M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$8.7M |
| 2 |
AG
Algert Global
San Francisco,
California
|
-$939K |
| 3 |
D.E. Shaw & Co
New York
|
-$511K |
| 4 |
BA
Boston Advisors
Boston,
Massachusetts
|
-$469K |
| 5 |
Renaissance Technologies
New York
|
-$338K |
